UnitedHealth stock at EUR 364.40, up 1.34% premarket
Published on 11/12/2026 at 08:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for UnitedHealth investors
- UnitedHealth Group's investor calendar lists no upcoming events.
- Medical costs, healthcare regulation and execution remain central factors for the group.
- The company has published its third-quarter 2026 results and continues to flag legal and regulatory risks.
UnitedHealth stock traded at EUR 364.40 on Lang & Schwarz at 08:48 CET on Thursday, November 12, 2026, 1.34 percent above the Xetra close of Wednesday, November 11, at EUR 359.60.
The move puts the stock above the previous Xetra session's closing level before the European market opens. UnitedHealth Group's investor relations page lists no upcoming events and highlights medical-cost management, healthcare regulation, government programs and litigation as factors that can affect results.
What UnitedHealth investors should watch
The company has published its third-quarter 2026 results, while its investor materials continue to emphasize execution risks across care strategies, pharmacy services and public-sector contracts. That leaves medical-cost trends and regulatory developments as key variables for the shares.
UnitedHealth also warns that changes in Medicare rules, legal actions concerning participation in the Medicare program and government investigations could affect its financial performance. The company says its forward-looking statements are subject to material uncertainty.
Broader trading takes place against the backdrop of the S&P 500.
